Mary L Staicu1, Dipekka Soni2, Kelly M Conn3, Allison Ramsey2. 1. Pharmacy Department, Rochester General Hospital, Rochester, New York. Electronic address: mary.staicu@rochesterregional.org. 2. Pharmacy Department, Rochester General Hospital, Rochester, New York. 3. St. John Fisher College, Wegmans School of Pharmacy, Rochester, New York.
Abstract
BACKGROUND: The negative effect of the penicillin allergy label on antibiotic use and patient outcomes has brought to light the need for thorough penicillin allergy assessments and heightened practitioner education. OBJECTIVE: To evaluate practitioner knowledge of penicillin allergy and the clinical approach to the patients with penicillin allergy. METHODS: An electronic survey was distributed to attending physicians, residents, pharmacists, nurse practitioners, and physician assistants practicing adult inpatient medicine at 2 community-based teaching hospitals from February to April 2016. RESULTS: A total of 276 (39%) of 716 practitioners completed surveys were analyzed. Most respondents were attending physicians (45%) with more than 10 years of experience (53%). Approximately half of the respondents indicated that they were unfamiliar with the rate of cross-reactivity between penicillin and cephalosporin (46%), carbapenem (42%), and monobactam (48%) antibiotics. When evaluating the role of penicillin skin testing and temporary induction of drug tolerance in the case vignettes, only 41% and 19% of respondents appropriately considered these options as the leading antibiotic management plan, respectively. Despite acknowledging the need for allergy/immunology consultation in clinical scenarios, 86% of respondents indicated that they never consult an allergist or immunologist or do so only once per year. Overall, pharmacists had a better understanding of the natural history of penicillin allergy and antibiotic cross-reactivity (P < .05). CONCLUSION: There is an overall limited understanding of the management of patients with a history of penicillin allergy in the hospital setting, where collaborative efforts between allergy and nonallergy health care practitioners are sparse. The expansion of a multidisciplinary approach may optimize antimicrobial prescribing in this subset of patients.
BACKGROUND: The negative effect of the penicillinallergy label on antibiotic use and patient outcomes has brought to light the need for thorough penicillinallergy assessments and heightened practitioner education. OBJECTIVE: To evaluate practitioner knowledge of penicillinallergy and the clinical approach to the patients with penicillinallergy. METHODS: An electronic survey was distributed to attending physicians, residents, pharmacists, nurse practitioners, and physician assistants practicing adult inpatient medicine at 2 community-based teaching hospitals from February to April 2016. RESULTS: A total of 276 (39%) of 716 practitioners completed surveys were analyzed. Most respondents were attending physicians (45%) with more than 10 years of experience (53%). Approximately half of the respondents indicated that they were unfamiliar with the rate of cross-reactivity between penicillin and cephalosporin (46%), carbapenem (42%), and monobactam (48%) antibiotics. When evaluating the role of penicillin skin testing and temporary induction of drug tolerance in the case vignettes, only 41% and 19% of respondents appropriately considered these options as the leading antibiotic management plan, respectively. Despite acknowledging the need for allergy/immunology consultation in clinical scenarios, 86% of respondents indicated that they never consult an allergist or immunologist or do so only once per year. Overall, pharmacists had a better understanding of the natural history of penicillinallergy and antibiotic cross-reactivity (P < .05). CONCLUSION: There is an overall limited understanding of the management of patients with a history of penicillinallergy in the hospital setting, where collaborative efforts between allergy and nonallergy health care practitioners are sparse. The expansion of a multidisciplinary approach may optimize antimicrobial prescribing in this subset of patients.
Authors: Anca M Chiriac; Aleena Banerji; Rebecca S Gruchalla; Bernard Y H Thong; Paige Wickner; Paul-Michel Mertes; Ingrid Terreehorst; Kimberly G Blumenthal Journal: J Allergy Clin Immunol Pract Date: 2018-12-17
Authors: Mary L Staicu; David Vyles; Erica S Shenoy; Cosby A Stone; Taylor Banks; Kristin S Alvarez; Kimberly G Blumenthal Journal: J Allergy Clin Immunol Pract Date: 2020-10
Authors: Elizabeth W Covington; Spencer H Durham; Christopher M Bland; P Brandon Bookstaver; Elias B Chahine; Jonathan C Cho; Fernando Diggs; Bruce M Jones; Jeffrey A Kyle; Kayla R Stover; Jamie L Wagner; Peter J Hughes Journal: J Pharm Technol Date: 2021-12-21
Authors: Risa N Fuller; Mary Grace Baker; Mauli B Desai; Patricia L Saunders-Hao; Shradha Agarwal; Gopi Patel; Saloni Agrawal; Sarah H Schaefer Journal: Antimicrob Steward Healthc Epidemiol Date: 2021-07-12
Authors: Katherine Collins; Kristina Rueter; Michaela Lucas; David Sommerfield; Aine Sommerfield; Nazim Khan; Britta S von Ungern-Sternberg Journal: J Paediatr Child Health Date: 2022-05-03 Impact factor: 1.929
Authors: Marta Wanat; Sibyl Anthierens; Christopher C Butler; Judy M Wright; Naila Dracup; Sue H Pavitt; Jonathan A T Sandoe; Sarah Tonkin-Crine Journal: Antibiotics (Basel) Date: 2018-08-06